Posted On: 03/14/2014 9:37:15 AM
Post# of 63648
$NVLX - News events to pay attention to will be the cloning of the cancer-drug-activating cells that are required for the clinical trials http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)